Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2007. Start Trial.
Date Value
July 31, 2026 -8.921M
April 30, 2026 -9.093M
January 31, 2026 -8.045M
October 31, 2025 -6.635M
July 31, 2025 -6.243M
April 30, 2025 -4.508M
January 31, 2025 -4.872M
October 31, 2024 -4.904M
July 31, 2024 -3.263M
April 30, 2024 -2.347M
January 31, 2024 -2.772M
October 31, 2023 -4.497M
July 31, 2023 -7.038M
April 30, 2023 -14.64M
January 31, 2023 -14.46M
October 31, 2022 -16.03M
July 31, 2022 -15.06M
April 30, 2022 -7.831M
January 31, 2022 -7.000M
October 31, 2021 -3.486M
July 31, 2021 -1.560M
April 30, 2021 -0.4767M
January 31, 2021 0.5014M
October 31, 2020 1.001M
July 31, 2020 -0.5278M
Date Value
April 30, 2020 -1.010M
January 31, 2020 -2.072M
October 31, 2019 -2.464M
July 31, 2019 -2.472M
April 30, 2019 -2.407M
January 31, 2019 -2.363M
October 31, 2018 -2.268M
July 31, 2018 -1.890M
April 30, 2018 -2.678M
January 31, 2018 -2.675M
October 31, 2017
July 31, 2017
April 30, 2017
January 31, 2017
June 30, 2016
March 31, 2016
December 31, 2015 -0.0028M
September 30, 2015 0.0415M
June 30, 2015 -0.0047M
March 31, 2015 -0.0026M
December 31, 2014 -0.0318M
September 30, 2014 -0.2554M
June 30, 2014 -0.0275M
March 31, 2014 -0.0249M
December 31, 2013 -0.0444M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Repligen Corp. 134.86M
Bio-Techne Corp. 292.07M
BioLife Solutions, Inc. 16.88M
Maravai Lifesciences Holdings, Inc. -25.26M
MaxCyte, Inc. -22.98M